Mustang Bio, Inc. Stock Price

NasdaqCM:MBIO Community·US$8.2m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
7 Fair Values set on narratives written by author

Create a narrative

MBIO Share Price Performance

US$1.13

-8.17 (-87.85%)

US$1.13

-8.17 (-87.85%)

US$1.13

Tue, 16 Dec 25

Share Pricen/a

MBIO Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks

1 Reward

View Full Analysis

Mustang Bio, Inc. Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: -0.32
: 0%
: 0%
: 0%

View Full Analysis

About MBIO

Founded: 2015
Employees: 6
CEO: Manuel Litchman
WebsiteView website: www.mustangbio.com

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases. It develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-101, an IL13Ra2 CAR T cell program for glioblastoma; and MB-108 for the treatment of herpes simplex virus-1 oncolytic virus C134. The company was incorporated in 2015 and is headquartered in Waltham, Massachusetts.